Dow Jones 30 Stocks SEC Filings — May 18, 2026

18-05-2026

Soluna Holdings reported Q1 2026 revenue of $9.4M, up 58% YoY from $5.9M and 2% sequentially, driven by Dorothy 2, Dorothy 1A, and Kati 1. However, net loss widened to $17.9M from $7.4M YoY due to higher equity compensation and financing costs, while Adjusted EBITDA loss increased to $2.1M from $1.6M. Hashprice compression (-18%) hurt proprietary mining and profit share revenue, and several projects (Dorothy 1B at -15% gross margin, Kati 1 with a $262K loss) underperformed. Subsequent to quarter end, the company acquired the 150 MW Briscoe Wind Farm for $53M and full equity of Dorothy 1A for $16.5M, positioning for future growth.

• · Dorothy 1B generated a -15% gross margin loss in Q1 2026 vs positive margin in prior periods.
• · Kati 1 reported a $262K loss in its first quarter due to ramp-up costs.
• · Cash decreased from $76.4M (Dec 2025) to $68.6M (Mar 2026).
• · Total assets increased slightly to $190.4M from $187.9M at year-end 2025.
• · Contract termination liability remained at $19.3M.
• · Subsequent to quarter, KPMG appointed as independent auditor.
• · Project Kati 1B first 12 MW phase installation underway with Cormint containers.

18-05-2026

Coca-Cola Europacific Partners plc issued a letter urging shareholders to vote FOR Resolutions 7, 9, and 25 at the May 28, 2026 AGM, despite recommendations against from ISS (on all three) and a "RED" designation from IVIS on Resolution 25. The company argues that the buyback-related waiver (Resolution 25) is necessary to execute its €1bn share buyback programme, and that non-independent directors on the Remuneration Committee (Manolo Arroyo and José Ignacio Comenge) are appropriate given their roles as shareholder representatives and no conflicts. The board emphasizes that Glass Lewis recommends FOR all resolutions and that Olive's maximum potential ownership would be capped at 41.4% with further increases subject to Takeover Code safeguards.

• · Olive has owned in excess of 34% of CCEP since its formation in 2016, and its percentage holding has only modestly increased since then.
• · ISS has recommended voting AGAINST Resolution 25 every year for the past ten years, and its policy has not been updated to reflect the PLSA's 2020 change on Rule 9 waivers.
• · If CCEP repurchases all shares under the current buyback programme (at prevailing price), it would acquire substantially less than 10% of the company's share capital.
• · Glass Lewis recommends voting FOR all resolutions, while IVIS gave a RED designation to Resolution 25 but acknowledged it is a matter for shareholder judgment.
• · The Panel on Takeovers and Mergers has already reviewed and agreed to waive Rule 9, subject to Independent Shareholders' approval via Resolution 25.
• · Mr. Arroyo and Mr. Comenge are not independent directors, but the Remuneration Committee already comprises a majority of INEDs (60% independent).
• · The company states that a vote AGAINST Resolution 25 would effectively block Resolutions 29 and 30 (authority to purchase own shares) and prevent the buyback execution.

18-05-2026

LiveRamp Holdings, Inc. entered into a definitive merger agreement to be acquired by a subsidiary of Publicis Groupe S.A. for $38.50 per share in cash, representing a significant premium. The board unanimously approved the transaction, which is subject to stockholder and regulatory approvals, including CFIUS, with an outside date of May 16, 2027. Concurrently, the company issued financial results for Q4 and fiscal year ended March 31, 2026, but canceled its earnings conference call due to the merger announcement.

• · Merger consideration is $38.50 per share in cash, no stock component.
• · Termination fee of $32,350,000 payable by either party under specified circumstances (Superior Proposal or regulatory failure).
• · Outside date for closing is May 16, 2027, with automatic 3-month extension if only regulatory conditions remain.
• · Equity awards: Options, restricted stock, RSUs, and PSUs convert into restricted cash awards with vesting tied to qualifying terminations within 24 months post-merger.
• · PSU awards: FY25 grants convert at 128% of target; FY26 grants at 139% of target; post-2025 grants at target level.
• · Company canceled its scheduled Q4 FY2026 earnings conference call due to the merger announcement.
• · Merger requires stockholder approval, HSR, non-U.S. antitrust, and CFIUS approvals.
• · Board unanimously approved and recommends stockholders to vote in favor.

18-05-2026

Permianville Royalty Trust announced a monthly cash distribution of $0.014000 per unit, payable June 12, 2026. Oil volumes fell 16.9% while gas volumes dropped 19.8% month-over-month, though average realized prices improved significantly (oil +17.0%, gas +38.9%). Cash receipts from oil remained flat at $2.0 million, while natural gas receipts rose $0.3 million to $3.1 million. Operating expenses decreased $0.6 million to $2.3 million, but capital expenditures increased $0.5 million to $1.5 million, and an additional $0.4 million was withheld for a development expense reserve (total reserve now $1.5 million).

• · Distribution payable June 12, 2026 to holders of record on May 29, 2026
• · Net profits interest calculation uses reported oil production for February 2026 and natural gas production for January 2026, with accrued costs incurred in March 2026
• · Current month average oil price $60.90/Bbl vs prior $52.05/Bbl; natural gas $5.00/Mcf vs $3.60/Mcf
• · Oil volumes 32,098 Bbls (1,146 Bbls/D) vs prior 38,192 Bbls; gas volumes 615,097 Mcf (19,842 Mcf/D) vs prior 766,861 Mcf
• · Operating expenses decreased $0.6M to $2.3M; CapEx increased $0.5M to $1.5M
• · Additional $0.4M withheld for development reserve; total reserve $1.5M

18-05-2026

Babcock & Wilcox Enterprises announced the pricing of an underwritten public offering of 10,810,811 shares of common stock at $18.50 per share, with gross proceeds of approximately $200 million. The net proceeds will be used to prepay and reborrow under its Credit Agreement to fund project-related capital, working capital, growth initiatives including AI data center power generation and BrightLoop technology commercialization, potential acquisitions, and balance sheet strengthening. The offering, led by B. Riley Securities, is expected to close on May 18, 2026, but will dilute existing shareholders may face dilution from the new shares and the underwriters' 30-day option to purchase an additional 15%.

• · The offering is being made under a shelf registration statement effective April 8, 2025.
• · Underwriters have a 30-day option to purchase up to an additional 15% of the shares at the public offering price less discounts.
• · B. Riley Securities is the lead book-running manager; Craig-Hallum and Lake Street Capital Markets are joint book-running managers; Northland Capital Markets is co-manager.
• · The offering is expected to close on May 18, 2026.
• · Use of proceeds includes prepaying Credit Agreement amounts and reborrowing to fund project-related capital and working capital needs for steam turbine and boiler production capacity.

18-05-2026

O'Reilly Automotive held its 2026 Annual Meeting on May 14, 2026, where all nine director nominees were elected, including Executive Chairman Greg Henslee. The Board also approved a $2,000,000 stock option award for Henslee vesting over four years. Shareholders approved advisory NEO compensation and ratified Ernst & Young as auditors, but voted against a shareholder proposal on political spending. Notably, director John R. Murphy received substantial against votes of 78.2M, though still elected.

• · Stock option award for Henslee has exercise price equal to closing price on grant date, vests 25% annually over four years, expires in 10 years.
• · Among directors, John R. Murphy received the highest against votes: 78,226,419 (13.2% of votes cast excluding broker non-votes), while Maria A. Sastre received the fewest against: 5,012,735.
• · Shareholder proposal on political spending was defeated with 369,391,768 votes against vs 292,670,896 for; 7,748,205 abstentions and 71,176,543 broker non-votes.
• · Advisory approval of NEO compensation passed with 613,777,069 for, 53,995,103 against.
• · Ratification of Ernst & Young as auditor passed with 695,116,311 for, 45,241,655 against.
• · Board committees (Audit, Compensation, Governance) remain unchanged.

18-05-2026

Hilton Worldwide Holdings Inc. filed an 8-K on May 18, 2026, covering Items 5.02 (officer/director changes and compensatory arrangements) and 5.07 (shareholder vote results). Specific details on the individuals involved or vote outcomes are not provided in the available filing metadata, preventing a directional assessment. Without the actual filing text, no positive or negative metrics can be extracted.

• · Filing date: May 18, 2026, suggests event(s) occurred shortly before (typically within 4 business days).
• · Presence of both Item 5.02 and Item 5.07 indicates the filing covers both a leadership/compensation change and a shareholder meeting outcome.
• · No details on who was appointed or resigned; no vote tallies; no compensation amounts.

18-05-2026

Bally’s Corp reported Q1 2026 consolidated revenue of $755.7M, up 28.3% YoY, driven by strong growth in Bally's Intralot B2C (+31.0%) and North America Interactive (+35.9%). However, Casinos & Resorts EBITDAR grew only 1.2% to $96.2M due to elevated competition and higher shared services costs, while North America Interactive remained EBITDA-negative at $(7.1)M (though improving $0.9M YoY). The company advanced major projects including the Chicago casino topping out, the $4.0B Bally's Bronx development, and refinancing with a $1.1B credit facility and full repayment of the $1.47B term loan.

• · Bally's entered a new $1.1B credit facility due 2031 and completed sale-leaseback of Lincoln Casino Resort real estate to GLP Capital.
• · Proceeds from Intralot transaction, term loan, and sale-leaseback were used to fully repay the $1.47B term loan due 2028.
• · Casinos & Resorts growth was notably strong at Bally's Baton Rouge (landside Dec 2025) and Marquette (landside Feb 2026), partially offset by elevated competition in Shreveport and Dover.
• · Bally's Intralot B2B segment includes Intralot's B2B and B2G post-acquisition; legacy B2B EBITDAR was flat YoY despite US lottery revenue decline.
• · North America Interactive recorded negative Segment Adjusted EBITDAR of $7.1M, an improvement of $0.9M from prior year, driven by top-line growth and cost management.
• · Bally's holds a 38% equity interest in Star Entertainment following loan conversion in Q4 2025; Star refinanced with a $390M facility from WhiteHawk Capital Partners in May 2026.
• · UK online iGaming revenue grew 10.5% YoY in constant currency despite the higher remote gaming duty effective April 1, 2026; Bally's has a mitigation plan in place.
• · Spain B2C revenue remained stable at 1.7% YoY growth in constant currency.
• · The $500M New York license fee and $115M golf course contingent consideration were finalized in Q1 2026.
• · Bally's holds Minority Business Enterprise (MBE) certification from NMSDC.

18-05-2026

This definitive proxy statement (DEF 14A) solicits shareholder votes for the election of trustees at the joint annual meeting of Clough Global Equity Fund (GLQ) and two affiliated funds, scheduled for July 6, 2026. For GLQ, three independent trustees – Edmund J. Burke, Clifford J. Weber, and Vincent W. Versaci – are nominated for three-year terms expiring at the 2029 annual meeting. The filing includes meeting logistics, record date (May 8, 2026), and outstanding share counts, but contains no financial performance data or operational updates.

• · Joint annual meeting will be held virtually via telephone conference on July 6, 2026 at 9:00 a.m. Mountain Time.
• · Record date for shareholders entitled to vote is May 8, 2026.
• · Shareholders must register by emailing shareholdermeetings@computershare.com by 5:00 p.m. Eastern Time on June 30, 2026 to participate.
• · GLQ has 18,738,120.8920 common shares outstanding; GLV has 12,409,682.8250 shares; GLO has 42,766,222.3190 shares.
• · All GLQ nominees are independent trustees; GLQ's three nominees (Burke, Weber, Versaci) are all current Class III trustees standing for re-election.
• · GLV elects one trustee (Adam D. Crescenzi); GLO elects two trustees (DiGravio and McNally).
• · Quorum requires a majority of shares entitled to vote present or by proxy.
• · If no contrary instructions, proxies will be voted FOR all nominees.
• · The funds' most recent annual report (fiscal year ended Oct 31, 2025) is available upon request.

18-05-2026

At its Annual General Meeting on May 14, 2026, AXIS Capital Holdings Limited shareholders elected all three Class II director nominees (W. Marston Becker, Michael Millegan, Lizabeth Zlatkus) to serve until 2029. They also approved, in a non-binding vote, the compensation of named executive officers, and ratified Deloitte Ltd. as independent auditor for fiscal year 2026. While all proposals passed with strong majorities, director W. Marston Becker received notably higher opposition (approximately 6.1 million votes against) compared to the other two directors (about 3.9 million each).

• · Broker non-votes totaled 5,069,503 for director elections and the say-on-pay proposal, and zero for auditor ratification.
• · All director nominees received over 56 million votes in favor; however, W. Marston Becker's against vote (6,127,270) was substantially higher than Michael Millegan's (3,974,529) and Lizabeth Zlatkus's (3,910,818).
• · Auditor ratification received the highest absolute vote in favor (64,530,374) and the narrowest approval margin relative to shares outstanding.

18-05-2026

Bally's Chicago, Inc. reported Q1 2026 revenue of $33.1M, up 13.1% from $29.3M in the combined Q1 2025 (predecessor + successor periods). Net loss attributable to the company narrowed significantly to $7.8M from $23.2M in the prior year period. However, cash used in operations surged to $64.5M from $17.2M, driven by a large increase in accounts receivable and other assets, and the company's reliance on parent financing grew as due to Bally's Corporation rose to $85.9M from $19.6M at year-end. Total stockholders' deficit deepened to $142.7M from $134.9M.

• · Accounts receivable, net increased to $83.4M at March 31, 2026 from $64.8M at December 31, 2025, largely due to $81.6M due from GLP.
• · Due to related party (Bally's Corporation) surged from $19.6M to $85.9M, indicating increased short-term financing from the parent.
• · Redeemable non-controlling interest decreased from $511.8M to $491.9M, reflecting net loss allocation of $19.9M.
• · Capital expenditures were only $0.7M in Q1 2026 versus $33.9M in combined Q1 2025, suggesting a slowdown in investment.
• · The company had $13.1M cash at quarter end, up from $12.0M at year-end, but still low relative to cash burn.

18-05-2026

Aureus Greenway Holdings Inc. (Nasdaq: AGH) announced a change in its trading symbol to 'PUSA' effective May 18, 2026, in anticipation of its previously announced proposed business combination with Autonomous Power Corporation (Powerus). The combined company would operate as Powerus Corporation and continue trading under the 'PUSA' ticker. No action is required by stockholders. The filing includes forward-looking statements regarding the proposed business combination and the ticker change.

• · The ticker symbol change was originally announced on May 14, 2026 for an effective date of May 15, 2026, but Nasdaq later informed that the effective date would be May 18, 2026.
• · The company's common stock has a par value of $0.001 per share and is listed on The Nasdaq Stock Market LLC.
• · The company qualifies as an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.
• · There can be no assurance that the proposed business combination with Powerus will be completed on the anticipated terms or at all.

18-05-2026

18-05-2026

Artificial Intelligence Technology Solutions Inc. (AITX) announced via an 8-K filed on May 18, 2026, that its subsidiary RAD is launching SCANNA, a product designed to unlock smarter security from existing cameras. The announcement was made through a press release attached as Exhibit 99.1. No financial details were provided in this filing.

• · The press release is attached as Exhibit 99.1 to the Form 8-K.
• · The filing was made under Item 8.01 (Other Events) and Item 9.01 (Exhibits).

18-05-2026

Chiba Bank and Chiba Kogyo Bank have agreed on a 1:1 share transfer ratio for their management consolidation via a joint share transfer, forming Chiba Financial Group effective April 1, 2027. The consolidation targets FY2028 consolidated ROE of ~11%, profit attributable to owners of parent of ¥140B or more, and OHR around 40%. While Chiba Kogyo Bank has higher net assets per share (¥2,498 vs ¥1,781) and EPS forecast (¥135.48 vs ¥127.97), it pays a much lower dividend (¥10 vs ¥52), and its stock price has historically shown volatility due to speculation and a prior large shareholder stake. The 1:1 ratio falls within all valuation ranges provided by third-party appraisers.

• · Chiba Bank acquired 19.9% of Chiba Kogyo Bank shares from Ariake Capital on March 28, 2025
• · A memorandum of understanding was announced on September 29, 2025
• · The share transfer ratio of 1:1 was agreed after repeated negotiations, and falls within all three valuation ranges from both third-party appraisers (Mitsubishi UFJ Morgan Stanley Securities and Mizuho Securities)
• · Future elimination of outward preferred dividend flows through acquisition and cancellation of Chiba Kogyo Bank preferred shares is a positive factor for Chiba FG common shareholders
• · Target Tier 1 common equity capital ratio (Basel III full implementation finalization basis, excluding valuation differences on securities) of 10.5–11.5% for FY2028
• · Chiba Kogyo Bank's stock price had been volatile due to speculative reporting and the holding period by Ariake Capital, but such influences have diminished over time

18-05-2026

Perma-Fix Environmental Services announced an underwritten public offering of common stock to fund capacity upgrades at its Northwest Richland facility, continued development of its patent-pending Perma-FAS technology for PFAS destruction, and general corporate purposes. Craig-Hallum is acting as sole managing underwriter. The offering is subject to market conditions, with no assurance of completion or final terms.

• · The offering is made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-283555) declared effective on December 12, 2024.
• · The preliminary prospectus supplement and accompanying prospectus will be filed with the SEC and available on the SEC's website or from Craig-Hallum.

18-05-2026

Ziff Davis, Inc. announced its participation in the J.P. Morgan 54th Annual Global Technology, Media and Communications Conference on May 18, 2026. The presentation will be webcast. No financial or operational details were disclosed in this filing.

18-05-2026

The filing is an 8-K reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), indicating that CoreCivic held its annual meeting and/or special shareholder meeting on or around May 18, 2026, and voted on standard proposals. No specific vote results, financial metrics, or forward-looking guidance are provided in the summary, making it purely informational with no directional bias.

18-05-2026

Predictive Oncology Inc. filed an 8-K on May 18, 2026, reporting Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a mandatory disclosure of quarterly financial results. However, the filing summary provided does not include any specific financial metrics, performance changes, or forward-looking guidance, preventing a detailed assessment of the company's operational trends or material events.

18-05-2026

Faraday Future announced $25M in new convertible note financing, bringing total financing to $70M over two months (including $45M from April), sufficient to support Phase 1 of its EAI robotics strategy by end of 2026. The company raised its full-year shipment target to 1,500 units and declared a shift from liquidity-driven to capital-structure-driven financing. However, only $12.5M is immediately available to the operating account; the remainder is in controlled accounts subject to conditions, and the company continues to face significant risks including insufficient share capital and Nasdaq compliance requirements.

• · SEC investigation concluded with no penalties.
• · Founding team has fully returned to the company.
• · The $25M convertible notes are unregistered and subject to trading restrictions.
• · Of the $25M, $12.5M is directly in the operating account; the remaining $12.5M is in controlled accounts with conditions for release.
• · The full strategic plan (upgraded from Ten-Punch Combo to Five Key Transformations) will be unveiled in YT's Investor Weekly Report on Sunday.
• · Key application scenarios: education, security inspection, reception and guided tours, performance, and university research.
• · Company expects to move EAI Vehicle business away from high-cost short-term funding toward operating cash flow, industry partnerships, and long-term capital.

18-05-2026

Banzai International, Inc. filed an 8-K/A on May 18, 2026, reporting a Floor Price Amendment (May 15, 2026) to its loan agreement with CP BF Lending. The floor price for converting the outstanding convertible note was reduced from $50.00 to $4.50 per share (post-1-for-20 reverse stock split), while the conversion price remains 95% of the prior trading day's closing price subject to that floor. As of May 14, 2026, the outstanding note balance was $5,361,910, reflecting ongoing dilution risk for existing shareholders.

• · The Floor Price Amendment reduces the conversion floor from $50.00 to $4.50 (post-split), with conversion price at 95% of prior day's closing price subject to floor.
• · CP BF agreed to use commercially reasonable efforts to partially convert the note, with daily volume limit of 5% of aggregate daily trading volume (waivable by company).
• · A Suspension Period applies after the company pays at least $2M of the note's balance, suspending prepayment of proceeds from securities sales until 60 days or $10M gross proceeds received.
• · As of May 14, 2026, the outstanding note balance was $5,361,910, down from $10,758,774.75 at issuance.
• · Company failure to comply with Floor Price Amendment constitutes an Event of Default.

18-05-2026

Flux Power Holdings, Inc. entered into a committed equity facility with Roth Principal Investments, LLC, allowing the company to sell up to $40,000,000 of common stock at its sole discretion over a 36-month period. The agreement includes multiple purchase mechanisms (Market Open, Intraday, Pre-Market, Post-Market) and conditions such as a minimum stock price threshold of $0.50 per share. This facility provides potential capital but may lead to dilution for existing shareholders.

• · The per share purchase price for all purchase types is calculated at a fixed 3.0% discount to the applicable VWAP.
• · The registration rights agreement covers up to 38,461,538 shares of common stock.
• · The facility includes a threshold price of $0.50 per share, below which no purchases can be initiated on that trading day.
• · The company may also conduct Intraday Purchases after 10:00 a.m. and before 2:00 p.m. New York City time on qualifying trading days.
• · Pre-Market Purchases are limited to a maximum of 1,000,000 shares and up to 20% of trading volume, with notices delivered between 7:00 a.m. and 8:30 a.m. New York City time.
• · The company has no obligation to sell any shares under the agreement.

18-05-2026

Artivion completed its acquisition of Endospan Ltd., an Israeli developer of aortic instability treatments including the Nexus™ stent graft system. The all-cash transaction had a base purchase price of $175.0 million, with a net cash payment of approximately $131.3 million after offsetting existing loans. Additional contingent consideration of up to $200.0 million may be payable based on Nexus product performance approximately two years post-closing.

• · The acquisition was executed via exercise of an option originally granted under a Securities Purchase Option Agreement dated September 11, 2019, as amended on July 1, 2024 and January 9, 2026.
• · Payment was made by CryoLife Asia Pacific Pte. Ltd., a wholly owned subsidiary of Artivion.
• · The net purchase price after offsetting loans under the Amended and Restated Loan Agreement (dated July 1, 2024) was approximately $131.3 million.
• · Escrow accounts of $16.5 million (indemnity) and $1.0 million (adjustment) were established from the purchase price.

18-05-2026

LanzaTech Global, Inc. entered into a securities purchase agreement to sell 2,000,000 shares of common stock at $10.00 per share in a registered direct offering, generating gross proceeds of $20.0 million. Concurrently, the company amended its existing subscription agreement with LanzaTech Global SPV, LLC, lowering the cash balance threshold for additional share purchases from $40 million to $30 million. Net proceeds from the offering will be used for general corporate purposes.

• · The offering was conducted under an effective shelf registration statement on Form S-3 (File No. 333-279239).
• · Closing of the offering is expected on May 18, 2026.
• · The PIPE subscription amendment also provided that LT Global consented to the offering in connection with its consent rights over future financings.
• · The Company has until May 13, 2027, to require LT Global to purchase up to an additional $20.0 million of shares, subject to the lowered cash requirement of $30 million.

18-05-2026

Analysis unavailable

18-05-2026

ABVC Biopharma reported no revenue for Q1 2026, with net loss widening to $1,689,937 from $944,190 in Q1 2025, a 79% increase. Operating expenses surged 127% to $1,572,472, driven primarily by a 1,514% jump in stock-based compensation ($787,374 vs $48,773). Cash and cash equivalents plummeted 79% to $140,324 from $681,480, and total assets declined 6.3% to $19.7 million, reflecting continued cash burn with no top-line revenue.

• · Cash burn accelerated: net cash used in operations was $894,243 in Q1 2026 vs $539,833 in Q1 2025, a 65.7% increase.
• · Total current assets fell 74.1% to $648,848 from $2,501,343, driven by declines in cash and due from related parties.
• · Short-term bank and other loans decreased 88.3% to $88,737 from $755,512, while convertible notes payable remained unchanged.
• · Accumulated deficit grew to $78,418,603 from $76,858,361, reflecting continued losses.
• · No revenue was generated in either period; the company remains pre-revenue.
• · Stock-based compensation of $787,374 represents 50% of total operating expenses in Q1 2026, up from 7% in Q1 2025.

18-05-2026

Catheter Precision, Inc. reported Q1 2026 total revenues of $432K, a 202% increase from $143K in Q1 2025, driven by strong growth in Cardiac Electrophysiology product sales ($248K vs $143K) and the addition of a Private Aviation service segment ($184K). Net loss attributable to common stockholders improved to ($3,041K) from ($4,045K), and operating loss narrowed 35% to ($2,318K). However, cash used in operations increased 20% to ($2,796K), and the company ended the quarter with $441K in cash, down from $450K a year earlier. The quarter included an acquisition of a private aviation business, contributing $1.2M in cash outflow and adding $184K in service revenue.

• · The company acquired a private aviation business during Q1 2026, paying $1.2M in cash and issuing $4.8M in short-term notes and $5.8M in deferred consideration.
• · Goodwill increased from $0 to $9.7M and intangible assets from $15.2M to $22.3M due to the acquisition.
• · Private Aviation segment contributed $184K in service revenue (Luxe $42K, Hops $142K) and a segment net loss of $132K.
• · Cardiac Electrophysiology segment net loss was $1,558K, compared to total company net loss of $4,045K in Q1 2025 (prior period had no Private Aviation).
• · The company issued 392,608 shares of common stock and equity-classified contracts for $3.7M in proceeds during Q1 2026.
• · A deemed dividend of $1,360K was recorded on a warrant inducement offer.
• · Total liabilities increased to $25.9M from $9.2M, primarily due to acquisition-related debt.
• · The company had $9.2M in Level 3 fair value liabilities (royalties payable, deferred consideration, convertible notes).

18-05-2026

AstroNova, Inc. entered into a settlement agreement on May 15, 2026, resolving all claims related to the May 2024 acquisition of MTEX New Solution by AstroNova Portugal. Key terms include the transfer of an industrial property in Porto, Portugal (valued at €2.5 million) to AstroNova Portugal, waiver of lease amounts owed by MTEX, and release of personal guarantees by Mr. Ferreira. Pending arbitration proceedings in Portugal will be terminated upon property registration. The settlement removes legal uncertainties and provides AstroNova with a tangible asset without additional cash outlay.

• · The settlement includes a mutual release of all claims between the parties
• · Atlantiprestigio will waive its right to receive any amounts from MTEX under the lease agreement for the property
• · AstroNova and AstroNova Portugal agreed to cause Mr. Ferreira and his spouse to be released from certain personal guarantees for loans extended to MTEX
• · Pending arbitration proceedings in the Arbitration Center in Oporto, Portugal will be terminated upon definitive registration of the property
• · The settlement also addresses allocation of arbitration costs

18-05-2026

Global Business Travel Group, Inc. held its 2026 annual meeting on May 13, 2026, with 407,115,412 shares represented out of 523,342,918 entitled to vote. All four proposals passed with overwhelming shareholder support: the three Class I director nominees (Paul Abbott, Eric Hart, Kathleen Winters) were elected, the appointment of KPMG LLP as auditor was ratified, the advisory say-on-pay proposal was approved, and the amendment to the 2022 Equity Incentive Plan was adopted. The highest opposition was against the equity plan amendment with over 9.1 million votes against, but it still received approximately 96% support from votes cast.

• · The amendment to the 2022 Equity Incentive Plan received 390,956,846 votes for, 9,129,997 against, 3,640,938 abstain, and 3,387,631 broker non-votes, making it the proposal with the most opposition.
• · The advisory say-on-pay proposal had 402,377,712 votes for, 1,263,703 against, 86,366 abstain, and 3,387,631 broker non-votes.
• · Ratification of KPMG LLP as auditor had 406,430,176 votes for, 653,792 against, and 31,444 abstain, with no broker non-votes because it is a routine matter.
• · Total shares outstanding entitled to vote as of March 17, 2026: 523,342,918 shares of Class A common stock.

18-05-2026

Spring Valley Acquisition Corp. III filed an 8-K on May 18, 2026, disclosing Amendment No. 1 to its Business Combination Agreement with General Fusion Inc. and NewCo (1573562 B.C. Ltd.). The amendment modifies the transaction timeline so that the SPAC Redemption of shares occurs immediately prior to the SPAC Continuation (instead of after), and updates various definitions and conditions. The amendment also adopts a SPAC Equity Incentive Plan reserving 15% of post-closing SPAC Common Shares for issuance.

• · The amendment was executed on May 12, 2026, and amends the original Business Combination Agreement dated January 1, 2026.
• · The SPAC Redemption is now required to occur no later than immediately prior to the SPAC Continuation, rather than at Closing.
• · Redeeming Shareholders must have validly exercised Redemption Rights under Section 53.4 of the SPAC Memorandum and Articles of Association.
• · The SPAC Equity Incentive Plan will be a customary public company rolling evergreen plan, with initial share reserve equal to 15% of shares outstanding immediately after Closing.
• · The Plan of Arrangement and SPAC Closing Articles were replaced with updated versions attached as exhibits to the amendment.
• · The amendment is governed by the laws of British Columbia and attorns to the exclusive jurisdiction of courts in the Province of British Columbia.

18-05-2026

VIAVI Solutions announced a routine rotation of its Audit Committee chair, with independent director Joanne Solomon replacing Donald Colvin effective May 12, 2026, as part of board refreshment and succession planning. Additionally, independent director Doug Gilstrap was appointed to the Corporate Development Committee. No disagreements were involved in these changes.

• · Donald Colvin will continue to serve as an independent member of the Board and Audit Committee.
• · Joanne Solomon has served as an independent director since February 2022 and qualifies as an 'audit committee financial expert' under Regulation S-K.
• · Doug Gilstrap joined the Board in November 2022 and also serves on the Compensation Committee.

18-05-2026

The filing is an SEC Form 8-K filed by Vishay Intertechnology Inc. on May 18, 2026, covering Items 5.02 (departure/appointment of officers), 5.07 (submission of matters to vote), 8.01 (other events), and 9.01 (financial statements and exhibits). However, the filing summary provided contains no specific details on the nature of the officer change, the individuals involved, or any quantitative data. Without access to the full filing text, no actionable information can be extracted.

18-05-2026

18-05-2026

Clear Channel Outdoor Holdings, Inc. entered into a Third Amendment to its ABL Credit Agreement on May 15, 2026, to facilitate its planned merger under a February 9, 2026 Merger Agreement. The amendment extends the maturity date of revolving credit commitments for consenting lenders and adds $50,000,000 in incremental revolving commitments, bringing total revolving commitments to $250,000,000. The company also agreed to reduce its Term/Revolver Credit Agreement commitments to $0 and pay consent fees of 0.20% on existing commitments and 0.30% on incremental commitments.

• · The amendment is conditioned on the closing of the merger under the Agreement and Plan of Merger dated February 9, 2026.
• · Conditions to effectiveness include receipt of legal opinion from Freshfields US LLP, a solvency certificate, and certification of no Default or Event of Default.
• · The Term/Revolver Credit Agreement commitments will be reduced to $0 substantially concurrently with the Third Amendment Effective Date.
• · Consent fees are payable on or prior to the Merger Agreement Closing Date, and only if the closing occurs.
• · The Administrative Agent may require adjustments to participations in Letters of Credit and Swingline Loans to ensure pro-rata allocation among all Lenders after the incremental increase.

18-05-2026

Advanced Energy Industries Inc. entered into a call option transaction (convertible note hedge) with a dealer as part of its offering of Convertible Senior Notes due 2031. The hedge is intended to reduce potential dilution from conversion of the notes, using a Modified American call option structure under an ISDA Master Agreement. Many specific terms (e.g., strike price, premium, number of options) were left as placeholders in the filing, indicating a draft template or that final amounts were not disclosed.

• · The call option is subject to an ISDA 2002 Master Agreement with the laws of New York as governing law.
• · The option is styled as 'Modified American' and can be automatically exercised on conversion dates after the Free Convertibility Date (February 15, 2031).
• · The transaction includes provisions for automatic exercise of remaining repurchase options before the Expiration Date (May 15, 2031).
• · The Shares are AEIS common stock (par value $0.001 per share) listed on the Nasdaq Global Select Market.
• · The confirmation references both a Base Call Option and an Additional Call Option (greenshoe), but the filing does not specify which this covers.

18-05-2026

The filing indicates a Form 8-K covering Items 5.02 (Officer/Board changes) and 5.07 (Shareholder vote) for CVS Health Corp on May 18, 2026. However, the actual filing text is not provided, so no specific individuals, positions, or voting outcomes can be extracted. Without the filing content, no actionable analysis is possible.

18-05-2026

Virgin Galactic Holdings, Inc. redeemed $10,000,000 of its 9.80% First Lien Notes due 2028 by issuing 3,768,536 shares of common stock, reducing cash interest obligations. However, after the redemption, approximately $202.5 million in aggregate principal of the notes remains outstanding, and the company continues to evaluate steps to improve liquidity as it prepares for commercial operations in Q4 2026. The transaction dilutes existing shareholders but is part of a broader capital management and cash preservation strategy.

• · The shares were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933.
• · The redemption was announced on April 30, 2026, and completed on May 18, 2026 (the Redemption Date).
• · The Indenture governing the notes is dated December 18, 2025, as amended by the First Supplemental Indenture dated April 24, 2026.
• · The redemption price was 100% of principal plus accrued interest.
• · Virgin Galactic expects to begin commercial operations in the fourth quarter of 2026.
• · The company's common stock trades on the New York Stock Exchange under the symbol SPCE.

18-05-2026

Arrive AI Inc. entered into a Standstill Agreement with investor Streeterville Capital, LLC on May 14, 2026, restricting the investor from delivering Purchase Notices under outstanding Pre-Paid Purchases from May 14, 2026 to December 31, 2026, unless the company's stock trades at a price at least 15% above the Nasdaq Minimum Price. No additional cash or property was exchanged. The standstill terminates upon material breach or default by the Company.

• · Investor may submit purchase notices during the standstill period on any trading day where the stock price is at least 15% greater than the Nasdaq Minimum Price under Rule 5635(d).
• · The standstill period runs from May 14, 2026 to December 31, 2026.
• · No additional cash or other property consideration was exchanged for the Standstill Agreement.
• · Outstanding pre-paid purchases remain in full force and effect except for the delivery restriction during the standstill.

18-05-2026

This DEFA14A filing provides additional proxy soliciting materials related to Victoria's Secret & Co.'s earlier proxy statement filed on March 20, 2026. The document contains forward-looking statements and provides contact information for investor relations and media inquiries. No new financial or operational data is disclosed.

• · Investor relations contact: investorrelations@victoria.com
• · Media relations: Edelman Smithfield VSCO@edelmansmithfield.com
• · The definitive additional proxy materials were filed with the SEC on May 18, 2026, referencing an earlier filing on March 20, 2026.

18-05-2026

Unconventional Investor, LLC filed its 13F-HR for the quarter ending March 31, 2026, disclosing a portfolio of 46 holdings totaling $210,608,937. The portfolio is heavily weighted toward broad-market ETFs, with the largest position being the Vanguard Total Stock Market ETF at $66,719,788 (31.7% of portfolio). Notable individual equity stakes include Berkshire Hathaway Class B ($26,395,774), Berkshire Hathaway Class A ($5,026,980), NVIDIA ($1,985,374), Planet Labs ($1,397,500), Apple ($1,172,869), and Costco ($530,101). The portfolio also includes a small speculative position in Wheels Up Experience ($8,608).

• · The portfolio includes 7 shares of Berkshire Hathaway Class A valued at $5,026,980.
• · The smallest disclosed position is Wheels Up Experience with 16,666 shares valued at $8,608.
• · The filing was signed by Principal Paul P. O'Leary and filed on May 18, 2026.
• · The portfolio holds a mix of US equities, international equities, fixed income ETFs, real estate ETFs, and currency ETFs.
• · No options or derivative positions are reported; all holdings are equity securities (common stock or ETFs).

18-05-2026

Nicolet Bankshares held its 2026 annual meeting on May 18, 2026, with all 12 director nominees elected and the ratification of Forvis Mazars, LLP as auditor passing overwhelmingly. However, the non-binding advisory vote on executive compensation (say-on-pay) showed significant shareholder dissent, with approximately 32.7% of votes cast against the proposal (4,938,131 Against vs 10,078,861 For).

• · All 12 director nominees were elected with For votes ranging from 13,750,490 (John N. Dykema) to 14,910,311 (Glen E. Tellock); the lowest For percentage (excluding broker non-votes) was 91.0% for John N. Dykema.
• · Auditor ratification received 16,862,884 For votes vs 31,390 Against and 35,540 Abstain; no broker non-votes were cast because this was a routine matter.
• · Say-on-pay vote had 10,078,861 For, 4,938,131 Against, 87,770 Abstain, and 1,825,052 broker non-votes; the Against count represents strong opposition.

18-05-2026

This definitive proxy statement (DEF 14A) for Clough Global Opportunities Fund (GLO) calls for a joint annual meeting of shareholders on July 6, 2026. Shareholders are asked to elect two trustees (Karen A. DiGravio, Independent, and Kevin J. McNally, Interested) each for a three-year term expiring at the 2029 annual meeting. No financial performance or quantitative business data is provided in the filing.

• · Record date for voting: May 8, 2026.
• · Meeting date: July 6, 2026 at 9:00 a.m. Mountain Time (virtual telephone conference).
• · Shareholders must register by email by 5:00 p.m. ET on June 30, 2026 to participate.
• · Proxy materials available at https://www.proxy-direct.com/clo-35189.
• · Annual report for fiscal year ended October 31, 2025 is available upon request.
• · Each GLO share entitles holder to one vote per full share.
• · The Board is divided into three classes; nominees are for Class II (term expiring at 2029 annual meeting).

18-05-2026

On May 12, 2026, directors Derek Small and Mark DiPaolo resigned from Innoviva's board to focus on Syndeio BioSciences (a company Innoviva has invested in), with no disagreement related to Innoviva's operations. On May 18, 2026, the board elected Josephine Linden as a new independent director; she will receive initial equity awards totaling $331,250 in restricted stock units and options for 9,166 shares. The changes are part of normal governance adjustments and do not indicate any negative performance trends.

• · The resignations were to allow Messrs. Small and DiPaolo to focus on the growth of Syndeio BioSciences, a company in which Innoviva has made a series of investments.
• · Josephine Linden was a Partner and Managing Director at Goldman Sachs for over 25 years and holds an MBA from the University of Chicago.
• · Linden is expected to serve on the Board's Audit Committee and qualifies as an independent director under SEC and Nasdaq rules.
• · The Initial RSU Award vests in equal annual installments over two years; the Prorated Annual RSU Award and Option vest in a single installment at the earlier of the next annual meeting or one year from the effective date.
• · All unvested RSUs and options will immediately vest upon death, disability, or a change in control of the company.

18-05-2026

Clough Global Dividend & Income Fund (GLV) filed a definitive proxy statement (DEF 14A) for a joint annual meeting of shareholders to be held virtually on July 6, 2026. The sole proposal for GLV shareholders is the election of one independent trustee nominee, Adam D. Crescenzi, for a three-year term expiring at the 2029 annual meeting. The filing also covers trustee elections for two affiliated funds (GLQ and GLO) and provides record date (May 8, 2026) and share counts: GLV has 12,409,682.8250 common shares outstanding. No financial results or period-over-period comparisons are included.

• · Joint annual meeting of GLV, GLQ, and GLO will be held virtually via telephone conference call on July 6, 2026 at 9:00 a.m. Mountain time.
• · Shareholders must register by email to shareholdermeetings@computershare.com no later than 5:00 p.m. Eastern Time on June 30, 2026 to participate.
• · The Board of each fund is divided into three classes with staggered three-year terms.
• · Each Fund's most recent annual report (fiscal year ended October 31, 2025) is available upon request.
• · Proxy materials available at https://www.proxy-direct.com/clo-35189.

18-05-2026

Zevia PBC's subsidiary, Zevia LLC, amended its Secured Revolving Line of Credit with Bank of America, extending the maturity date to February 22, 2030, and reducing the credit spread adjustment on the Term SOFR margin to 0.10%. The amendment also revised financial covenants, including a minimum liquidity requirement of $7,000,000 until the fixed charge coverage ratio reaches 1.00x for two consecutive quarters.

• · The First Amendment was entered on May 15, 2026, and reported on May 18, 2026.
• · Maturity date extended from original 2022 agreement to February 22, 2030.
• · Fixed charge coverage ratio covenant of 1.00 to 1.00 applies if availability drops below $3 million or 17.5% of borrowing base, or upon certain events of default.

18-05-2026

NanoVibronix reported a significant decline in revenue for Q1 2026, down 36.3% YoY to $653K, and swung to a negative gross loss of $(55K) from a $369K gross profit in the prior year period. Operating expenses surged 64.6% to $3,656K, primarily driven by higher selling and general administrative costs, leading to a net loss of $(3,822K) compared to $(1,872K) in Q1 2025. The company raised $3.9M through the issuance of common and preferred stock and warrants, but also recorded a massive deemed dividend of $16.974M related to a down round feature on Series H Preferred Stock, resulting in a net loss available to common stockholders of $(22,621K). Cash and cash equivalents fell 47% to $2,235K from $4,224K at year-end 2025, reflecting heavy cash burn from operations.

• · Net loss available to common stockholders was $(22.621M) due to preferred stock dividends and deemed dividends, including a $16.974M deemed dividend for a down round feature on Series H Preferred Stock.
• · Common shares outstanding surged from 1,100,413 at Dec 31, 2025 to 3,700,908 at Mar 31, 2026, primarily from conversion of Series H Preferred Stock and accrued dividends into 2,600,495 common shares.
• · The company repurchased 2,573 shares of Series X Preferred Stock for $1.56M.
• · Prepaid expenses and other accounts receivable increased sharply from $391K to $1,334K, driven by a $804K rise in prepaid expenses.
• · Deferred revenue was fully recognized during the quarter, dropping from $175K to $0.
• · Goodwill remained unchanged at $29.082M.
• · The company had an arbitration liability of $2.285M at March 31, 2026, slightly up from $2.252M.

18-05-2026

Limbach Holdings announced the appointment of Michael Reed to the newly created position of Executive Vice President and Chief Operating Officer, effective May 18, 2026. Reed, a 7-year veteran of the company, most recently served as SVP Midwest Regional Manager and previously led integration of acquisitions including Consolidated Mechanical and Pioneer Power. The move aims to strengthen operational execution, support scalable growth, and drive a high-performance culture across the organization's 21 offices and 1,600 team members.

• · Michael Reed joined Limbach in 2019 as Vice President, Branch Manager.
• · Subsequent roles included Vice President of Operational Risk Management, Senior Vice President Integrations Leader (2024), and Senior Vice President Midwest Regional Manager (May 2025).
• · As COO, Reed will oversee both organic growth and strategic acquisitions, as well as culture and employee engagement.
• · The COO position is newly created, indicating a structural expansion of the executive team.

18-05-2026

NBT Bancorp Inc. filed an 8-K on May 18, 2026, disclosing that it will present at its 2026 Annual Meeting of Stockholders on May 19, 2026. The presentation slides are available on the company's website. This disclosure is made under Regulation FD and does not contain specific financial results or material non-public information.

• · The Form 8-K is filed under Item 7.01 Regulation FD Disclosure.
• · The presentation is scheduled for May 19, 2026, and slides are posted on the company's investor relations page.